News

Mankind Pharma (Mankind) has received government of Himachal Pradesh’s approval to establish another facility in the state, stated the company. Reportedly, the company has installed its second unit

Ironwood Pharmaceuticals (Ironwood ) and Astellas Pharma have entered into an agreement providing Astellas exclusive rights to develop and commercialise the investigational compound linaclotide in Japan, Indonesia, Korea,

Novavax has begun a Phase IIa clinical study of its trivalent seasonal influenza VLP vaccine candidate in healthy adults 60 years of age or older. The company said

Trin Pharma has appointed Stefan Wohlfeil as a new CEO of the company, effective from October 6, 2009. Reportedly, Dr Stefan Wohlfeil previously held the position of chief

QuantRx has been developing a platform of point-of-care (POC) devices to facilitate diagnosis of critical metabolic markers, such as those associated with thyroid disease, malignant cancers, therapeutic drugs

Clinipace has closed its acquisition of Worldwide Clinical Research, (WWCR) on October 26th, 2009. With the acquisition, Clinipace has changed its name to Clinipace Worldwide. Reportedly, with specific

Qiagen has signed a definite agreement to acquire SABiosciences, a privately-held developer and manufacturer of disease- and pathway-focused PCR assay panels. The company said that transaction is valued

The Health Canada has accepted for review EpiCept’s New Drug Submission (NDS) for Ceplene (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first

Shire has launched Intuniv (guanfacine) extended release tablets in pharmacies across the US for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.